(2R)-2-({[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}amino)-N-(2,4-difluorophenyl)-2-phenylacetamide |
BL 918 NEW |
2101517-69-3 |
2,6-dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide |
GDC-046;GDC 046 |
1258292-64-6 |
DIM-C-pPhCO2Me |
DIM-C-pPhCO2Me |
151358-48-4 |
BCI |
BCI |
1245792-51-1 |
1H-Benzimidazole-6-carboxylic acid, 2-[1-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]-, methyl ester |
METHYL 2-(1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE-6-CARBOXYLATE |
2097938-51-5 |
5H-Benzocycloheptene-8-carboxylic acid, 3,4,6-trihydroxy-2-methoxy-5-oxo-, hexyl ester |
1416324-85-0 |
1416324-85-0 |
INNO206 |
ALDOXORUBICIN |
1361644-26-9 |
Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
(3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone |
(3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone |
431996-53-1 |
1-amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile |
1-amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile |
150651-39-1 |
IWP-O1 |
IWP-O1 |
2074607-48-8 |
Mitochonic acid 5 |
1354707-41-7 |
1354707-41-7 |
GSK2795039 |
1415925-18-6 |
1415925-18-6 |
SR 0987 |
303126-97-8 |
303126-97-8 |
DG172 (dihydrochloride) |
1361504-77-9 |
1361504-77-9 |
MSA-2 |
MSA-2 |
129425-81-6 |
LOC-14 |
2-((4-(环丙烷羰基)哌嗪-1-基)甲基)苯并[D]异噻唑-3(2H)-酮 |
877963-94-5 |
EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
N-(4,5-dihydronaphtho[1,2-d]thiazol-2-yl)-2-(3,4-dimethoxyphenyl)acetamide |
557782-81-7 |
557782-81-7 |
8-Epidiosbulbin E acetate |
8-Epidiosbulbin E acetate |
91095-48-6 |